Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 10;30(14):2913.
doi: 10.3390/molecules30142913.

Chirality Transfer and Oxazolidine Formation in Reaction of L and D Enantiomers of β-Hydroxy Amino Acids with Nitrogenous Carboxaldehydes and Nickel(II)

Affiliations

Chirality Transfer and Oxazolidine Formation in Reaction of L and D Enantiomers of β-Hydroxy Amino Acids with Nitrogenous Carboxaldehydes and Nickel(II)

Cynthia T Brewer et al. Molecules. .

Abstract

The reaction of either the L (2S3R) or D (2R3S) enantiomers of H2N-C*H(R)CO2- (R = -C*H(OH)CH3 or -C*H(OH)CH(CH3)2) and the L (2S) or D (2R) enantiomers of H2N-C*H(C(CH3)2OH)CO2- with imidazole-4-carboxaldehyde and nickel(II) acetate in methanol yields a single stereoisomer of an oxazolidine. There is retention of chirality on ring positions 4 and 5 (if Cβ is chiral) of the oxazolidine, Cα and Cβ of the parent amino acid, and transfer of chirality to the newly generated stereogenic centers, ring positions 3, the amino acid nitrogen atom, NAA, and 2, the aldehyde carbon atom, Cald. Specifically, when Cα has an S configuration, both NAA and Cald are formed as R. Likewise, a Cα which is R results in both NAA and Cald being formed as S. For example, the reaction of L threonine (Cα is S and Cβ is R) with 4-imidazolecarboxaldehyde in the presence of nickel(II) gives the facial Λ NiL2, where L is (2R, 3R, 4S, 5R) 4-carboxylato-5-methyl-2-(4-imidazolyl)-1,3-oxazolidine. The same reaction with D threonine produces the enantiomeric Δ complex of (2S, 3S, 4R, 5S) 4-carboxylato-5-methyl-2-(4-imidazoyl)-1,3-oxazolidine. The high stereospecificity is thought to be based on the fused three-ring structure of the characterized nickel complexes in which the hydrogen atoms of Cα, NAA, and Cald must be cis to one another. Identical reactions occur with 2-pyridine carboxaldehyde and LT or DT. In contrast, the reactions of L allo threonine (2S3S) and the primary alcohols, L or D serine, give the conventional meridionally coordinated aldimine product.

Keywords: beta hydroxy amino acids; chirality transfer; homochirality; oxazolidine; threonine.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Sketch of serine (R = H) threonine (R = CH3) ligation (STL) method of coupling an N terminal residue with S or T residue to another polypeptide. The proposed mechanism goes through an oxazolidine, whose numbering is depicted.
Figure 2
Figure 2
Chirality transfer in the reaction of chiral phenylglycinol with a salicylaldehyde, a prochiral aldehyde. On further reaction with nickel(II), the imine ligand gives the illustrated oxazolidine. Note the three-atom sequence in the product, C*Phenyl glycinol-N*Phenylglycinol-C*ald, is SRS or RSR for S or R phenylglycinol, respectively. An * after the symbol of an atom indicates that it is chiral.
Figure 3
Figure 3
Line drawings and abbreviations of aldehydes employed in this study.
Figure 4
Figure 4
The L ((left) hand side) and D ((right) hand side) enantiomers of the five βOHAAs examined. One-letter symbols are used for serine (S), threonine (T), valine (V), and leucine (L). For LT and LβOHL, Cα is S and Cβ is R, while for the D enantiomers, Cα is R and Cβ is S. For L and D, βOHV Cα is S and R, respectively, and Cβ is achiral. For LalloT, both Cα and Cβ are S, and in the enantiomer, both are R.
Figure 5
Figure 5
The reaction of the L enantiomer of the βOHAAs with either 4Im or 5Me4Im. The products of LS with 5Me4Im and LT with 4Im are labeled Ni(LSAld5Me4Im)2 and Ni(LTOx4Im)2, respectively. Use of the D enantiomer of the βOHAA results in formation of the enantiomer of the pictured product.
Figure 6
Figure 6
Labeling of the donor atoms of the aldimine (left) and oxazolidine (right) complexes, OCA, NAA, and NIm and the other ligand atoms that define the chelate rings, CCA, Cα, Cβ, OOx, CIm, and Cald. If Py rather than Im is used as the aldehyde, the NIm and CIm symbols are replaced with NPy and CPy.
Figure 7
Figure 7
The reaction of the anion of glycine or L alanine with 2-pyridinecarboxaldehyde gives the aldimine complex which on addition of Ni(II) and reduction of the imine gives facial coordination of the ligand.
Figure 8
Figure 8
Ni(LTOx4Im)2 with omission of hydrogen atoms for clarity. The pseudo-three-sided box is easily seen for the bottom ligand. The five-atom carboxylate and imidazole sides are on the left and right, respectively, with the oxazolidine ring on the bottom. Note that the NAA atoms are cis and NIm atoms are trans. Color codes: Ni (green); O (red); N (purple); C (gray).
Figure 9
Figure 9
The labeling of the three fused five-membered rings and their component atoms present in all eight βOHAA complexes (L and D enantiomers). The rings are far from coplanar. The carboxylate and imidazole/pyridine rings are ~perpendicular to one another and form the left and right sides of the pseudo-three-sided box. The oxazolidine ring forms the bottom of the box and is bent down from the two sides.
Figure 10
Figure 10
The overlayed structures of Ni(LTOx4Im)2 and Ni(LβOHLOx4Im)2. Hydrogen atoms have been omitted for clarity. The overlayed atoms are nickel and each of the six donor atoms in each complex. The RMS is 0.0861. Color codes: Ni (green); O (red); N (purple); C (gray).
Figure 11
Figure 11
Diagram of Ni(LTOx4Im)2 (left) and Ni(DTOx4Im)2 (right) complexes. The two are mirror images of one another. Only one of the ligands is shown for clarity. The important CαNAACald linkage is beneath the nickel and is SRR for LT and RSS for DT. Cβ is in the foreground and is R and S for LT and DT, respectively. Color codes: Ni (green); O (red); N (purple); C (gray); H (yellow).
Figure 12
Figure 12
Structure of bivalvane, (C10H15)2, showing one of the two fused three five-membered rings. The three atoms that link the rings together and their hydrogen atoms are shown as spheres to highlight the linkage. Note that the three hydrogen atoms of the linkage are all cis, as are the present oxazolidine complexes. Color codes: C (gray); H (yellow).

Similar articles

  • Sickle Cell Disease.
    Bender MA, Carlberg K. Bender MA, et al. 2003 Sep 15 [updated 2025 Feb 13]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2003 Sep 15 [updated 2025 Feb 13]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301551 Free Books & Documents. Review.
  • The Black Book of Psychotropic Dosing and Monitoring.
    DeBattista C, Schatzberg AF. DeBattista C, et al. Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
  • Short-Term Memory Impairment.
    Cascella M, Al Khalili Y. Cascella M, et al. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31424720 Free Books & Documents.
  • Management of urinary stones by experts in stone disease (ESD 2025).
    Papatsoris A, Geavlete B, Radavoi GD, Alameedee M, Almusafer M, Ather MH, Budia A, Cumpanas AA, Kiremi MC, Dellis A, Elhowairis M, Galán-Llopis JA, Geavlete P, Guimerà Garcia J, Isern B, Jinga V, Lopez JM, Mainez JA, Mitsogiannis I, Mora Christian J, Moussa M, Multescu R, Oguz Acar Y, Petkova K, Piñero A, Popov E, Ramos Cebrian M, Rascu S, Siener R, Sountoulides P, Stamatelou K, Syed J, Trinchieri A. Papatsoris A, et al. Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
  • Citrullinemia Type I.
    Quinonez SC, Lee KN. Quinonez SC, et al. 2004 Jul 7 [updated 2022 Aug 18]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2004 Jul 7 [updated 2022 Aug 18]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301631 Free Books & Documents. Review.

References

    1. Pichon-Barre D., Zhang Z., Cador A., Vives T., Roisnel T., Basle O., Jarrige L., Cavallo L., Falivene L., Mauduit M. Chiral oxazolidines acting as transientlhydroxy-alkyl-functionalized N-heterocyclic carbenes: An efficient route to gold and copper complexes for asymmetric catalysis. Chem. Sci. 2022;13:8773–8780. doi: 10.1039/D2SC02908A. - DOI - PMC - PubMed
    1. Wolf C., Xu H. Asymmetric catalysis with chiral oxazolidine ligands. Chem. Commun. 2011;47:3339–3350. doi: 10.1039/c0cc04629a. - DOI - PubMed
    1. Saleem A., Kobielska P.A., Harms K., Katsikogianni M.G., Telford R., Novitchi G., Nayak S. Transition metal complexes of a versatile polyalkoxy oxazolidine-based ligand derived from in situ cyclization. Dalton Trans. 2018;47:6156–6165. doi: 10.1039/C7DT04634K. - DOI - PubMed
    1. Ng C.-H., Wang W.-S., Chong K.-V., Win Y.-F., Neo K.-E., Lee H.-B., San S.-L., Rahman R., Leong W. Ternary copper(II)-polypyridyl enantiomers: Aldol-type condensation, characterization, DNA-binding recognition, BSA-binding and anticancer property. Dalton Trans. 2013;42:10233–10243. doi: 10.1039/c3dt50884f. - DOI - PubMed
    1. Lee K., Ng Y., Wang W., Ng P., Chan C., Lai J., Davamani F., Chitra E., Lim W., Ganguly R., et al. Enantiomeric pairs of ternary copper(ii) complexes and their aldol-type condensation products: Synthesis, characterization, and anticancer and epigenetic properties. Dalton Trans. 2019;48:4987–4999. doi: 10.1039/C9DT00506D. - DOI - PubMed

Grants and funding

LinkOut - more resources